© 2021 West Virginia Public Broadcasting
Telling West Virginia's Story
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Does The United States Need The AstraZeneca Vaccine?

A new trial of the AstraZeneca vaccine in the U.S. shows that it is 79 percent effective in preventing symptomatic COVID-19.
A new trial of the AstraZeneca vaccine in the U.S. shows that it is 79 percent effective in preventing symptomatic COVID-19.

A new study shows the AstraZeneca COVID-19 vaccine is 79 percent effective against symptomatic disease, according to a statement by the company. The same trial also showed a 100 percent efficacy in preventing hospitalization. The new study was based in the United States and it could provide the framework for emergency authorization by the Food and Drug Administration.

Some European countries paused their use of that vaccine due to fears of potential rare blood clotting, though subsequent studies have shown the shot does not increase the risk for blood clots.

Find all our coverage of the COVID-19 crisis here.

Does the United States actually need the AstraZeneca vaccine? How quickly could it get emergency authorization?

Copyright 2021 WAMU 88.5. To see more, visit WAMU 88.5.


WVPB is local news, education, music, and entertainment for West Virginia.
Your donation today will help keep us strong and vital.